A patient with Werner's syndrome and erythroleukemia: just coincidence?

Leukemia & Lymphoma
C BartalT Yermiyahu

Abstract

Werner's syndrome is a rare clinical entity and approximately 150 cases have been reported in the medical literature. Werner's syndrome, inherited by autosomal recessive transmission, is characterized primarily by a short stature, premature greying and balding, trophic ulceration of the legs, diabetes mellitus and hypogonadism. These features combine to present a picture of adult progeria. In this brief report we describe a 51-year-old Bedouin male with Werner's syndrome, diagnosed as erythroleukemia (AML-6), and presenting as acute pancytopenia. The patient died two months after diagnosis. This is a rare case of erythroleukemia in a patient with Werner's syndrome. We survey current knowledge of the cytogenetic pathogenesis of Werner's syndrome and erythroleukemia, and attempt to explain the possible link between these two rare syndromes.

References

Apr 17, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·M Goto, K Murata
Mar 1, 1977·Clinical Pediatrics·R H RuvalcabaG M Martin
Sep 1, 1992·International Journal of Cell Cloning·J C Winkelmann
Jan 1, 1991·Leukemia Research·S R Zuhrie, S N Wickramasinghe
Apr 1, 1991·Japanese Journal of Clinical Oncology·H TsuchiyaA Kawashima
Sep 1, 1990·Zeitschrift für Orthopädie und ihre Grenzgebiete·H J Hesselschwerdt, J Heisel
Jan 1, 1990·Journal of Gerontology·S GoldsteinR J Shmookler Reis
Aug 15, 1988·American Journal of Ophthalmology·I KremerI Ben-Sira
Oct 1, 1988·Biomedical & Environmental Mass Spectrometry·E G de JongJ M van Rossum
Dec 19, 1970·Lancet·E Stecker, H A Gardner
Sep 1, 1974·The British Journal of Dermatology·J J GilkesR S Wells
Feb 1, 1982·Archives of Dermatology·R P HrabkoR A Schwartz
May 1, 1982·Journal of the American Geriatrics Society·K Murata, H Nakashima
Aug 1, 1980·The British Journal of Dermatology·W P de GrootM J Woerdeman
Mar 1, 1994·La Revue de médecine interne·C BeylotM Busquet
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·R G FaragherS Shall
Jun 1, 1993·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·R Thweatt, S Goldstein
Aug 1, 1965·Annals of Internal Medicine·T R RILEYG J HAMWI
Jan 1, 1988·The Physician and Sportsmedicine·P M Murray, J D Cantwell

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.